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A
DNA capsule fitted with aptamer
controlled target sensing has been
“woven” using a 7308-base single-
stranded DNA “thread” and 196 staple
oligonucleotides. The capsule enables
logic-gated molecular cargo delivery to
targeted cell surfaces.
Using DNA origami,
1 the group of Georg
Church has engineered a capsule that can
be loaded with molecular cargo and
unloaded upon binding to a desired target
cell.
2 The capsule was designed using
computer software, to have the shape of
a hexagonal barrel with open ends, and
dimensions of 35  35  45 nm. Each
~2.4 megadalton half-barrel is connected
covalently via DNA hinges at the rear. At
the front, locking and unlocking is
accomplished by the making and breaking
of short DNA duplexes at the left and
right anterior of the capsule. Each duplex
lock contains an aptamer attached to one
half-barrel domain, which in the locked
conformation is hybridized to a partially
complementary strand connected with the
other half-barrel domain. When presented
with its molecular target (coined antigen-
key), the aptamer-complement duplexes
dissociate forming aptamer-antigen-key
complexes. Simultaneous dissociation
of both aptamer-complement duplexes
unlocks the capsule, which open due to
the entropic penalty of capsule closure
combined with phosphate backbone repul-
sion between half-barrel domains thus
exposing its previously hidden inner
surfaces. Experiments using aptamer-
complement duplex lengths of 16–44 bp
revealed that the optimal lock length tested
(23 bp) was a compromise between
reducing spontaneous opening while
maintaining sensitivity and speed of
activation in the absence and presence
of antigen-key, respectively. Using the
above described design, only 48% of the
capsules could be closed. Capsule closure
was further enhanced to 97.5% using
additional guide staple strands that were
subsequently removed.
To enable cargo loading, short oligo-
nucleotides were conjugated to the cargo,
and capsule staples were correspondingly
modified with complementary sequences
at multiple internal attachment sites.
Theoretical considerations indicated sub-
stantial diffusion of appropriately sized
molecules through the open ends of the
capsule barrel structure. Thus, capsules
were loaded in their closed barrel con-
formation (simplifying handling) with
efficiencies averaging three Fab' antibody
fragments (range 0–5) or four 5 nm gold
nanoparticles (range 0–7) per capsule.
To assay capsule function, different
cancer cells were exposed to capsules
loaded with fluorescently labeled antibody
fragments against human leukocyte
antigen (HLA)-A/B/C. These cells all
expressed (HLA)-A/B/C and different
antigen-key combinations. Consequently,
capsule unlocking required the correct
aptamer-key combination and once
unlocked, target cells were labeled by the
cargo. Using this approach, six aptamer-
lock capsule combinations were tested
against six different cell types. Only cells
expressing correct keys promoted capsule
opening. Impressively, capsules equipped
with two different aptamer-locks correctly
required the corresponding two surface
antigen-keys for activation. In other
words, the capsules behaved as logical
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AND gates where an output requires two
separate simultaneous inputs.
To investigate target specificity further,
capsules were challenged with mixed cell
populations. In mixed Ramos/NKL
-/+
antigen-key expressing cell populations
(ratio 2:1), the target NKL cells were
selectively labeled. Similarly, in whole
blood/NKL mixtures (ratio 4:1) the NKL
cells were almost exclusively labeled (0.6%
non-target cell labeling). In Jurkat/Ramos
cell compositions, the target Jurkat cells
were correctly singled out in the range
10
6/10
6 down to 1/10
6 cells.
To explore whether capsules could be
used to mediate meaningful biological
signaling, bio-active cargo was used.
Capsules loaded with growth arrest pro-
moting antibody fragments induced
growth arrest in leukemic cells. Capsules
loaded with T-cell activating antibody
fragments promoted T-cell activation,
and enhanced T-cell activation was
achieved by additional capsule loading
with peptide (binding to one of the already
loaded antibody fragments) known to
stimulate activation. Consequently, these
capsules may be used to impact cell
physiology.
Others have built comparable struc-
tures
3 but the aptamer-lock/capsule com-
bination used by Douglas and coworkers
2
appears to effectively harness the potential
of both the nano and aptamer world in
promoting targeted delivery. Their cap-
sules respond to predefined cell surface
cues and specifically single out the desired
target cells, and as pointed out by the
authors, with multivalent payload delivery.
Together, the presently described achieve-
ments (see ref. 2) increase prospects for a
“magic bullet” type delivery system that
improves specificity and reduces toxicity of
certain drugs.
To this end, several questions remain
unanswered. The toxicity of the vehicle
itself remains unknown. The lifetime of
the intact closed capsule state in humans is
unknown; important in preventing pre-
mature cargo access. Capsule stability
might be compromised during hepatic
passage. The aptamer-complement locks
in particular would appear vulnerable to
exonuclease digestion. Simple lock modi-
fication with synthetic DNA analogs could
help ameliorate such potential problems.
Functionally, the DNA capsules
resemble well-described lipid-based nano-
particles, which are already used in the
clinic for targeted delivery in cancer
therapy.
4 There are important differences
though. Whereas the present capsules
deliver their cargo to the cell surface,
lipid-based nanoparticles pass through the
endocytotic pathway. Thus DNA capsules
may be useful when using surface active
or cell permeable compounds whereas
liposomal vehicles are preferred with
compounds that have intracellular targets
and are cell impermeable (e.g., siRNA).
Additional basic research is required to
explore the potential of aptamer controlled
DNA capsules but the present advance-
ments provide a great leap toward a
practical application.
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